This content is from: France

France: Generic drugs and comparative advertising

A recent case found that a generic pharmaceutical company can use the name of a branded drug in comparative advertising in France. Philippe Lods of Lavoix examines how branded pharmaceutical companies can defend themselves

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial